The use of haloperidol in the agitated, critically ill pediatric patient with burns

Rebeccah L. Brown, Arlene Henke, David G Greenhalgh, Glenn D. Warden

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Haloperidol has become the drug of choice for sedation of the acutely agitated, delirious adult patient in the critical care setting because of its well-documented efficacy and lack of major side effects. Its use in the critically ill pediatric patient with burns has not been described. To determine the safety and efficacy of haloperidol in this population, the medical records of 30 critically ill pediatric patients with burns treated with haloperidol during the period 1986 to 1992 were reviewed. Our findings support the safe and effective use of haloperidol to treat severe agitation and delirium in the critically ill pediatric patient. The intravenous route appears to be more effective than the enteral route and should be considered when rapid, acute control of agitation is required.

Original languageEnglish (US)
Pages (from-to)34-38
Number of pages5
JournalJournal of Burn Care and Rehabilitation
Volume17
Issue number1
DOIs
StatePublished - Jan 1996
Externally publishedYes

Fingerprint

Haloperidol
Burns
Critical Illness
Pediatrics
Delirium
Critical Care
Small Intestine
Medical Records
Safety
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Rehabilitation
  • Surgery
  • Nursing(all)
  • Health Professions(all)
  • Emergency Medicine

Cite this

The use of haloperidol in the agitated, critically ill pediatric patient with burns. / Brown, Rebeccah L.; Henke, Arlene; Greenhalgh, David G; Warden, Glenn D.

In: Journal of Burn Care and Rehabilitation, Vol. 17, No. 1, 01.1996, p. 34-38.

Research output: Contribution to journalArticle

Brown, Rebeccah L. ; Henke, Arlene ; Greenhalgh, David G ; Warden, Glenn D. / The use of haloperidol in the agitated, critically ill pediatric patient with burns. In: Journal of Burn Care and Rehabilitation. 1996 ; Vol. 17, No. 1. pp. 34-38.
@article{03265933886f46bcba9385a80f90023f,
title = "The use of haloperidol in the agitated, critically ill pediatric patient with burns",
abstract = "Haloperidol has become the drug of choice for sedation of the acutely agitated, delirious adult patient in the critical care setting because of its well-documented efficacy and lack of major side effects. Its use in the critically ill pediatric patient with burns has not been described. To determine the safety and efficacy of haloperidol in this population, the medical records of 30 critically ill pediatric patients with burns treated with haloperidol during the period 1986 to 1992 were reviewed. Our findings support the safe and effective use of haloperidol to treat severe agitation and delirium in the critically ill pediatric patient. The intravenous route appears to be more effective than the enteral route and should be considered when rapid, acute control of agitation is required.",
author = "Brown, {Rebeccah L.} and Arlene Henke and Greenhalgh, {David G} and Warden, {Glenn D.}",
year = "1996",
month = "1",
doi = "10.1097/00004630-199601000-00009",
language = "English (US)",
volume = "17",
pages = "34--38",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The use of haloperidol in the agitated, critically ill pediatric patient with burns

AU - Brown, Rebeccah L.

AU - Henke, Arlene

AU - Greenhalgh, David G

AU - Warden, Glenn D.

PY - 1996/1

Y1 - 1996/1

N2 - Haloperidol has become the drug of choice for sedation of the acutely agitated, delirious adult patient in the critical care setting because of its well-documented efficacy and lack of major side effects. Its use in the critically ill pediatric patient with burns has not been described. To determine the safety and efficacy of haloperidol in this population, the medical records of 30 critically ill pediatric patients with burns treated with haloperidol during the period 1986 to 1992 were reviewed. Our findings support the safe and effective use of haloperidol to treat severe agitation and delirium in the critically ill pediatric patient. The intravenous route appears to be more effective than the enteral route and should be considered when rapid, acute control of agitation is required.

AB - Haloperidol has become the drug of choice for sedation of the acutely agitated, delirious adult patient in the critical care setting because of its well-documented efficacy and lack of major side effects. Its use in the critically ill pediatric patient with burns has not been described. To determine the safety and efficacy of haloperidol in this population, the medical records of 30 critically ill pediatric patients with burns treated with haloperidol during the period 1986 to 1992 were reviewed. Our findings support the safe and effective use of haloperidol to treat severe agitation and delirium in the critically ill pediatric patient. The intravenous route appears to be more effective than the enteral route and should be considered when rapid, acute control of agitation is required.

UR - http://www.scopus.com/inward/record.url?scp=0030050087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030050087&partnerID=8YFLogxK

U2 - 10.1097/00004630-199601000-00009

DO - 10.1097/00004630-199601000-00009

M3 - Article

C2 - 8808357

AN - SCOPUS:0030050087

VL - 17

SP - 34

EP - 38

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 1

ER -